Hawa Issa Munisi

  • Citations Per Year
Learn More
This research has focused on studying the central role that patents, strategic alliances and funding play in commercializing stem cells or regenerative medicine-related dedicated biotech firms in Japan. The paper bases its conceptual stand in the role of resource competencies as an object of commercializing and strategizing knowledge in dedicated biotech(More)
This article describes a recent trend in Japanese research, development and commercialization toward the application of stem cell technologies. Japan is the world's third largest economy and has a significant national presence in the pharmaceutical and biotechnology businesses; as such, stem cell R&D is abundant in the country. As indicated by the second(More)
Biotech Drug Discovery/Development Firms (Biotech DDFs), biotech firms that aim to discover and develop drugs, have recently started playing an important role in creating new drugs alongside traditional pharmaceutical companies. With the intention of proposing a policy that resolves issues concerning the cultivation of Biotech DDFs in Japan, we examined 44(More)
  • 1